News & Updates
Showing Hepatology articles
Showing
Show Multimedia Only

Survodutide safe to use in cirrhosis patients
27 Oct 2024
Treatment with survodutide, which has previously shown its efficacy in reducing body weight and glycaemia in people with obesity or type 2 diabetes, is well tolerated by patients with compensated or decompensated cirrhosis, reports a study.
27 Oct 2024

New model predicts HCC risk in noncirrhotic CHB patients
07 Oct 2024
A novel prognostic model based on the viral loads of hepatitis B virus (HBV) demonstrates its utility in predicting and stratifying the risk of hepatocellular carcinoma (HCC) in noncirrhotic patients with chronic hepatitis B (CHB) who are not yet receiving antiviral therapy.
07 Oct 2024

Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024
byStephen Padilla
Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.
29 Sep 2024





